Skip to main navigation
Neurogene Inc.
Toggle Menu
  • Home
  • About Us
    • Our Leadership
    • A Message from Our Founder
  • Our Technology
    • Gene Therapy Platform
    • Manufacturing
    • Partnerships
  • Our Pipeline
    • About Rett Syndrome
    • About NGN-401
    • Rett Syndrome Clinical Program
    • Other Programs
    • Expanded Access Policy
    • Publications
  • Patients & Families
    • Our Approach
    • What is Rett Syndrome?
    • Rett Syndrome Resources
    • Rett Syndrome Clinical Program
    • Patient Advocacy & Engagement at Neurogene
    • Communication Corner
    • Rare Disease Community Resources
  • Investors
  • Careers
    • Life at Neurogene
    • Open Positions
    • Benefits

SEC Filing Details

decorative diamond pattern
  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Corporate Governance
    • Governance Overview
    • Leadership Team
    • Board of Directors
    • Committee Composition
  • Financial Information
    • SEC Filings
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Shareholder Services
    • Investor FAQs
    • Email Alerts
    • RSS Feeds
    • Investor Contacts

Document Details

Form
S-8
Filing Date
Mar 24, 2026
Document Date
Mar 24, 2026
Form Description
Securities offered to employees pursuant to employee benefit plans
Filing Group
Registration Statements
Company
Neurogene Inc.
Issuer
NEUROGENE INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
XML - XBRL INSTANCE DOCUMENT
Neurogene Inc.
  • About Us
  • Our Technology
  • Our Pipeline
  • Patients & Families
  • Investors
  • Careers
© 2026 Neurogene Inc. All Rights Reserved. Theme by SiteOrigin
Privacy  |  Terms of Use  |  Contact Us
Facebook   Linkedin   X
Scroll to top